-
1
-
-
78049485263
-
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
-
Ferlay J., Shin H.R., Bray F., et al: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917, 2010
-
(2010)
Int J Cancer
, vol.127
, pp. 2893-2917
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
-
2
-
-
79959990351
-
-
(ed 2). Atlanta, GA, American Cancer Society
-
American Cancer Society: Global Cancer Facts & Figures (ed 2). Atlanta, GA, American Cancer Society, 2011. http://www.cancer.org/acs/groups/ content/@epidemiologysurveilance/documents/document/acspc-027766.pdf
-
(2011)
Global Cancer Facts & Figures
-
-
-
3
-
-
0018931869
-
Dose: A critical factor in cancer chemotherapy
-
Frei E. 3rd, Canellos G.P.: Dose: A critical factor in cancer chemotherapy. Am J Med 69:585-594, 1980
-
(1980)
Am J Med
, vol.69
, pp. 585-594
-
-
Frei III, E.1
Canellos, G.P.2
-
4
-
-
0021744793
-
The importance of dose intensity in chemotherapy of metastatic breast cancer
-
Hryniuk W., Bush H.: The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 2:1281-1288, 1984 (Pubitemid 15202705)
-
(1984)
Journal of Clinical Oncology
, vol.2
, Issue.11
, pp. 1281-1288
-
-
Hryniuk, W.1
Bush, H.2
-
5
-
-
0026558969
-
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy
-
Antman K., Ayash L., Elias A., et al: A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. J Clin Oncol 10:102-110, 1992
-
(1992)
J Clin Oncol
, vol.10
, pp. 102-110
-
-
Antman, K.1
Ayash, L.2
Elias, A.3
-
6
-
-
0024270188
-
High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer
-
Peters W.P., Shpall E.J., Jones R.B., et al: Highdose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. J Clin Oncol 6:1368-1376, 1988 (Pubitemid 19089024)
-
(1988)
Journal of Clinical Oncology
, vol.6
, Issue.9
, pp. 1368-1376
-
-
Peters, W.P.1
Shpall, E.J.2
Jones, R.B.3
Olsen, G.A.4
Bast, R.C.5
Gockerman, J.P.6
Moore, J.O.7
-
7
-
-
0027057246
-
High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: Follow-up report
-
Williams S.F., Gilewski T., Mick R., et al: Highdose consolidation therapy with autologous stemcell rescue in stage IV breast cancer: Follow-up report. J Clin Oncol 10:1743-1747, 1992 (Pubitemid 23059951)
-
(1992)
Journal of Clinical Oncology
, vol.10
, Issue.11
, pp. 1743-1747
-
-
Williams, S.F.1
Gilewski, T.2
Mick, R.3
Bitran, J.D.4
-
8
-
-
0030979431
-
High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America
-
Antman K.H., Rowlings P.A., Vaughn W.P., et al: High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in North America. J Clin Oncol 15:1870-1879, 1997 (Pubitemid 27209516)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.5
, pp. 1870-1879
-
-
Antman, K.H.1
Rowlings, P.A.2
Vaughan, W.P.3
Pelz, C.J.4
Fay, J.W.5
Fields, K.K.6
Freytes, C.O.7
Gale, R.P.8
Hillner, B.E.9
Holland, H.K.10
Kennedy, M.J.11
Klein, J.P.12
Lazarus, H.M.13
McCarthy Jr., P.L.14
Saez, R.15
Spitzer, G.16
Stadtmauer, E.A.17
Williams, S.F.18
Wolff, S.19
Sobocinski, K.A.20
Armitage, J.O.21
Horowitz, M.M.22
more..
-
9
-
-
4243753888
-
Superiority of tandem high-dose chemotherapy (HDC) versus optimized conventionally-dosed chemotherapy (CDC) in patients (pts) with metastatic breast cancer (MBC): The International Randomized Breast Cancer Dose Intensity Study (IBDIS I)
-
abstr 88
-
Crown J., Perey L., Lind M., et al: Superiority of tandem high-dose chemotherapy (HDC) versus optimized conventionally-dosed chemotherapy (CDC) in patients (pts) with metastatic breast cancer (MBC): The International Randomized Breast Cancer Dose Intensity Study (IBDIS I). Proc Am Soc Clin Oncol 22, 2003 (abstr 88). http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst - detail-view&confID=23&abstractID=103811
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
-
-
Crown, J.1
Perey, L.2
Lind, M.3
-
10
-
-
0035366299
-
An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications
-
Weiss R.B., Gill G.G., Hudis C.A.: An on-site audit of the South African trial of high-dose chemotherapy for metastatic breast cancer and associated publications. J Clin Oncol 19:2771-2777, 2001 (Pubitemid 32538184)
-
(2001)
Journal of Clinical Oncology
, vol.19
, Issue.11
, pp. 2771-2777
-
-
Weiss, R.B.1
Gill, G.G.2
Hudis, C.A.3
-
11
-
-
0034643512
-
Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
-
DOI 10.1056/NEJM200004133421501
-
Stadtmauer E.A., O'Neill A., Goldstein L.J., et al: Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer: Philadelphia Bone Marrow Transplant Group. N Engl J Med 342:1069-1076, 2000 (Pubitemid 30207689)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.15
, pp. 1069-1076
-
-
Stadtmauer, E.A.1
O'Neill, A.2
Goldstein, L.J.3
Crilley, P.A.4
Mangan, K.F.5
Ingle, J.N.6
Brodsky, I.7
Martino, S.8
Lazarus, H.M.9
Erban, J.K.10
Sickles, C.11
Glick, J.H.12
Luger, S.M.13
Klumpp, T.R.14
Litzow, M.R.15
Topolsky, D.L.16
-
12
-
-
4243878700
-
A randomized trial of high-dose chemotherapy (HDC) with autologous peripheral blood stem cell support (ASCT) compared to standard therapy in women with metastatic breast cancer: A National Cancer Institute of Canada (NCIC) Clinical Trials Group Study
-
abstr 82
-
Crump M., Gluck S., Stewart D., et al: A randomized trial of high-dose chemotherapy (HDC) with autologous peripheral blood stem cell support (ASCT) compared to standard therapy in women with metastatic breast cancer: A National Cancer Institute of Canada (NCIC) Clinical Trials Group Study. Proc Am Soc Clin Oncol 20, 2001 (abstr 82). http://www.asco.org/ASCOv2/Meetings/Abstracts? &vmview=abst-detail-view&confID=10&abstractID=82
-
(2001)
Proc Am Soc Clin Oncol
, vol.20
-
-
Crump, M.1
Gluck, S.2
Stewart, D.3
-
13
-
-
84921702226
-
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy forwomenwith metastatic breast cancer
-
CD003142
-
Farquhar C., Marjoribanks J., Basser R., et al: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy forwomenwith metastatic breast cancer. Cochrane Database Syst Rev 1:CD003142, 2003
-
(2003)
Cochrane Database Syst Rev
, vol.1
-
-
Farquhar, C.1
Marjoribanks, J.2
Basser, R.3
-
14
-
-
32944471342
-
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
-
CD003142
-
Farquhar C., Marjoribanks J., Basser R., et al: High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer. Cochrane Database Syst Rev 3:CD003142, 2005
-
(2005)
Cochrane Database Syst Rev
, vol.3
-
-
Farquhar, C.1
Marjoribanks, J.2
Basser, R.3
-
15
-
-
0037286183
-
High-dose chemotherapy for breast cancer: The French PEGASE experience
-
Roché H., Viens P., Biron P., et al: High-dose chemotherapy for breast cancer: The French PEGASE experience. Cancer Control 10:42-47, 2003 (Pubitemid 36231961)
-
(2003)
Cancer Control
, vol.10
, Issue.1
, pp. 42-47
-
-
Roche, H.1
Viens, P.2
Biron, P.3
Lotz, J.-P.4
Asselain, B.5
-
16
-
-
19944401062
-
High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: Final results of the French multicentric randomised CMA/PEGASE 04 protocol
-
DOI 10.1016/j.ejca.2004.09.006, PII S0959804904007476
-
Lotz J.P., Curé H., Janvier M., et al: High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: Final results of the French multicentric randomised CMA/PEGASE 04 protocol. Eur J Cancer 41:71-80, 2005 (Pubitemid 40036610)
-
(2005)
European Journal of Cancer
, vol.41
, Issue.1
, pp. 71-80
-
-
Lotz, J.-P.1
Cure, H.2
Janvier, M.3
Asselain, B.4
Morvan, F.5
Legros, M.6
Audhuy, B.7
Biron, P.8
Guillemot, M.9
Goubet, J.10
Laadem, A.11
Cailliot, C.12
Maignan, C.L.13
Delozier, T.14
Glaisner, S.15
Maraninchi, D.16
Roche, H.17
Gisselbrecht, C.18
-
17
-
-
14544306959
-
Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: Results of a randomized trial
-
DOI 10.1200/JCO.2005.06.072
-
Schmid P., Schippinger W., Nitsch T., et al: Up-front tandem high-dose chemotherapy compared with standard chemotherapy with doxorubicin and paclitaxel in metastatic breast cancer: Results of a randomized trial. J Clin Oncol 23:432-440, 2005 (Pubitemid 46224218)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.3
, pp. 432-440
-
-
Schmid, P.1
Schippinger, W.2
Nitsch, T.3
Huebner, G.4
Heilmann, V.5
Schultze, W.6
Hausmaninger, H.7
Wischnewsky, M.8
Possinger, K.9
-
19
-
-
0031720392
-
A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: Summation dose-intensity
-
Hryniuk W., Frei E. 3rd, Wright F.A.: A single scale for comparing dose-intensity of all chemotherapy regimens in breast cancer: Summation doseintensity. J Clin Oncol 16:3137-3147, 1998 (Pubitemid 28417437)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.9
, pp. 3137-3147
-
-
Hryniuk, W.1
Frei III, E.2
Wright, F.A.3
-
20
-
-
0037532157
-
Conventional-dose chemotherapy compared with highdose chemotherapy (HDC) plus autologous stem-cell transplantation (SCT) for metastatic breast cancer: 5-Year update of the 'Philadelphia Trial' (PBT-1)
-
abstr 169
-
Stadtmauer E.A., O'Neill A., Goldstein L.J., et al: Conventional-dose chemotherapy compared with highdose chemotherapy (HDC) plus autologous stem-cell transplantation (SCT) for metastatic breast cancer: 5-year update of the 'Philadelphia Trial' (PBT-1). Proc Am Soc Clin Oncol 21, 2002 (abstr 169). http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst-detail- view&confID=16&abstractID=169
-
(2002)
Proc Am Soc Clin Oncol
, vol.21
-
-
Stadtmauer, E.A.1
O'Neill, A.2
Goldstein, L.J.3
-
21
-
-
41549148282
-
Pegase 03: A prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer
-
DOI 10.1038/sj.bmt.1705935, PII 1705935
-
Biron P., Durand M., Roché H., et al: Pegase 03: A prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer. Bone Marrow Transplant 41:555-562, 2008 (Pubitemid 351472147)
-
(2008)
Bone Marrow Transplantation
, vol.41
, Issue.6
, pp. 555-562
-
-
Biron, P.1
Durand, M.2
Roche, H.3
Delozier, T.4
Battista, C.5
Fargeot, P.6
Spaeth, D.7
Bachelot, T.8
Poiget, E.9
Monnot, F.10
Tanguy, M.L.11
Cure, H.12
-
22
-
-
37849033195
-
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16
-
Crump M., Gluck S., Tu D., et al: Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. J Clin Oncol 26:37-43, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 37-43
-
-
Crump, M.1
Gluck, S.2
Tu, D.3
-
23
-
-
80052016382
-
Highdose chemotherapy (HDC) produces a superior rate of durable complete remission (DCR) compared to conventional chemotherapy in metastatic breast cancer (MBC): Mature results of the International Breast Cancer Dose-Intensity Study
-
suppl 3; abstr 1020
-
Crown J.P., Leyvraz S., Verrill M., et al: Highdose chemotherapy (HDC) produces a superior rate of durable complete remission (DCR) compared to conventional chemotherapy in metastatic breast cancer (MBC): Mature results of the International Breast Cancer Dose-Intensity Study. Ann Oncol 15:iii27, 2004 (suppl 3; abstr 1020)
-
(2004)
Ann Oncol
, vol.15
-
-
Crown, J.P.1
Leyvraz, S.2
Verrill, M.3
-
24
-
-
33646773983
-
High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: A therapy whose time has passed
-
Vogl D.T., Stadtmauer E.A.: High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: A therapy whose time has passed. Bone Marrow Transplant 37:985-987, 2006
-
(2006)
Bone Marrow Transplant
, vol.37
, pp. 985-987
-
-
Vogl, D.T.1
Stadtmauer, E.A.2
-
25
-
-
11144318239
-
Is high-dose chemotherapy dead?
-
Rodenhuis S.: Is high-dose chemotherapy dead? Eur J Cancer 41:9-11, 2005
-
(2005)
Eur J Cancer
, vol.41
, pp. 9-11
-
-
Rodenhuis, S.1
-
26
-
-
71549143528
-
Detecting an overall survival benefit that is derived from progression-free survival
-
Broglio K.R., Berry D.A.: Detecting an overall survival benefit that is derived from progression-free survival. J Natl Cancer Inst 101:1642-1649, 2009
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 1642-1649
-
-
Broglio, K.R.1
Berry, D.A.2
-
27
-
-
0036468810
-
High-dose versus standard chemotherapy in metastatic breast cancer: Comparison of cancer and leukemia group B trials with data from the autologous blood and marrow transplant registry
-
DOI 10.1200/JCO.20.3.743
-
Berry D.A., Broadwater G., Klein J.P., et al: High-dose versus standard chemotherapy in metastatic breast cancer: Comparison of Cancer and Leukemia Group B trials with data from the Autologous Blood and Marrow Transplant Registry. J Clin Oncol 20:743-750, 2002 (Pubitemid 34121009)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.3
, pp. 743-750
-
-
Berry, D.A.1
Broadwater, G.2
Klein, J.P.3
Antman, K.4
Aisner, J.5
Bitran, J.6
Costanza, M.7
Freytes, C.O.8
Stadtmauer, E.9
Gale, R.P.10
Henderson, I.C.11
Lazarus, H.M.12
McCarthy Jr., P.L.13
Norton, L.14
Parnes, H.15
Pecora, A.16
Perry, M.C.17
Rowlings, P.18
Spitzer, G.19
Horowitz, M.M.20
more..
-
28
-
-
80051991350
-
High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: Overview of 15 randomized trials
-
Berry D.A., Ueno N.T., Johnson M.M., et al: High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: Overview of 15 randomized trials. J Clin Oncol 29:3214-3223, 2011
-
(2011)
J Clin Oncol
, vol.29
, pp. 3214-3223
-
-
Berry, D.A.1
Ueno, N.T.2
Johnson, M.M.3
|